immunotherapy
Some gut microbial metabolites boost the efficacy of antitumor drugs by regulating the body’s immune response and could be used as a part of cancer therapy.
A new study published in Science claims that some gut microbes produce a metabolite that boosts the effect of a class of cancer drugs.
Researchers have created a catalog of the bacteria associated with all the cancer types. The findings could help to enhance the actions of anticancer drugs.
The modulation of the microbiota impacts on the efficacy of the new anti-PD-1 cancer therapies. We discuss it with Giorgio Trinchieri (NIH, USA).
The gut microbiota could boost the activity of immune cells. That's according to a new study published in the journal Immunity.
Researchers have engineered bacteria that can colonize tumors and deliver immunotherapy drugs. The study was published in Nature Medicine.
The relationship between bacteria and cancer is more and more investigated. We discuss it with Laurence Zitvogel, oncologist at the Institut Gustave Roussy.
We asked Laurence Zitvogel about the advances in the field of oncological immunotherapy and the role of microbiome.
